1104P Efficacy of immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD1 treatment: A EUMelareg real-world evidence study.
Saved in:
| Title: | 1104P Efficacy of immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD1 treatment: A EUMelareg real-world evidence study. |
|---|---|
| Authors: | Weichenthal, M.1 (AUTHOR), Schadendorf, D.2 (AUTHOR), Bastholt, L.3 (AUTHOR), Gavrilova, I.4 (AUTHOR), Haanen, J.B.A.G.5 (AUTHOR), Mangana, J.6 (AUTHOR), Espinosa, E.7 (AUTHOR), Svane, I-M.8 (AUTHOR), Wouters, M.9 (AUTHOR), Ellebæk, E.10 (AUTHOR), Mohr, P.11 (AUTHOR), Marques Rodas, I.12 (AUTHOR), Asher, N.13 (AUTHOR), Dummer, R.14 (AUTHOR), Gaudy Marqueste, C.15 (AUTHOR), Aya, F.16 (AUTHOR), Gogas, H.17 (AUTHOR), Lebbe, C.18 (AUTHOR), Rutkowski, P.19 (AUTHOR), Ascierto, P.A.20 (AUTHOR) |
| Source: | Annals of Oncology. 2023 Supplement 2, Vol. 34, pS665-S666. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 173099017 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 1104P Efficacy of immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD1 treatment: A EUMelareg real-world evidence study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Weichenthal%2C+M%2E%22">Weichenthal, M.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schadendorf%2C+D%2E%22">Schadendorf, D.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bastholt%2C+L%2E%22">Bastholt, L.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gavrilova%2C+I%2E%22">Gavrilova, I.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Haanen%2C+J%2EB%2EA%2EG%2E%22">Haanen, J.B.A.G.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mangana%2C+J%2E%22">Mangana, J.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Espinosa%2C+E%2E%22">Espinosa, E.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Svane%2C+I-M%2E%22">Svane, I-M.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wouters%2C+M%2E%22">Wouters, M.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ellebæk%2C+E%2E%22">Ellebæk, E.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mohr%2C+P%2E%22">Mohr, P.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Marques+Rodas%2C+I%2E%22">Marques Rodas, I.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Asher%2C+N%2E%22">Asher, N.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dummer%2C+R%2E%22">Dummer, R.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gaudy+Marqueste%2C+C%2E%22">Gaudy Marqueste, C.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Aya%2C+F%2E%22">Aya, F.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gogas%2C+H%2E%22">Gogas, H.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lebbe%2C+C%2E%22">Lebbe, C.</searchLink><relatesTo>18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rutkowski%2C+P%2E%22">Rutkowski, P.</searchLink><relatesTo>19</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ascierto%2C+P%2EA%2E%22">Ascierto, P.A.</searchLink><relatesTo>20</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2023 Supplement 2, Vol. 34, pS665-S666. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=173099017 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2023.09.2238 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S665 Titles: – TitleFull: 1104P Efficacy of immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD1 treatment: A EUMelareg real-world evidence study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Weichenthal, M. – PersonEntity: Name: NameFull: Schadendorf, D. – PersonEntity: Name: NameFull: Bastholt, L. – PersonEntity: Name: NameFull: Gavrilova, I. – PersonEntity: Name: NameFull: Haanen, J.B.A.G. – PersonEntity: Name: NameFull: Mangana, J. – PersonEntity: Name: NameFull: Espinosa, E. – PersonEntity: Name: NameFull: Svane, I-M. – PersonEntity: Name: NameFull: Wouters, M. – PersonEntity: Name: NameFull: Ellebæk, E. – PersonEntity: Name: NameFull: Mohr, P. – PersonEntity: Name: NameFull: Marques Rodas, I. – PersonEntity: Name: NameFull: Asher, N. – PersonEntity: Name: NameFull: Dummer, R. – PersonEntity: Name: NameFull: Gaudy Marqueste, C. – PersonEntity: Name: NameFull: Aya, F. – PersonEntity: Name: NameFull: Gogas, H. – PersonEntity: Name: NameFull: Lebbe, C. – PersonEntity: Name: NameFull: Rutkowski, P. – PersonEntity: Name: NameFull: Ascierto, P.A. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 10 Text: 2023 Supplement 2 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 34 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
